Filing Details

Accession Number:
0001140361-13-010511
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-04 20:58:40
Reporting Period:
2013-02-28
Filing Date:
2013-03-04
Accepted Time:
2013-03-04 20:58:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221590 Jacques Jean Bienaime C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-02-28 5,000 $12.99 18,545 No 4 M Indirect Shares held by Bienaime Family Trust
Common Stock Acquisiton 2013-03-04 5,000 $12.99 23,545 No 4 M Indirect Shares held by Bienaime Family Trust
Common Stock Disposition 2013-02-28 5,000 $58.00 18,545 No 4 S Indirect Shares held by Bienaime Family Trust
Common Stock Disposition 2013-03-04 5,000 $60.00 13,545 No 4 S Indirect Shares held by Bienaime Family Trust
Common Stock Disposition 2013-03-01 1,000 $59.14 119,401 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect Shares held by Bienaime Family Trust
No 4 M Indirect Shares held by Bienaime Family Trust
No 4 S Indirect Shares held by Bienaime Family Trust
No 4 S Indirect Shares held by Bienaime Family Trust
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Common Stock Disposition 2013-03-04 5,000 $0.00 5,000 $12.99
Common Stock Stock Option (right to buy) Common Stock Disposition 2013-02-28 5,000 $0.00 5,000 $12.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
347,500 2016-05-10 No 4 M Indirect
342,500 2016-05-10 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,000 Indirect Held in irrevocable trust for Guillaume Bienaime
Common Stock 10,000 Indirect Held in irrevocable trust for Pierre Bienaime
Common Stock 10,000 Indirect Held in irrevocable trust for Paul Bienaime
Common Stock 10,000 Indirect Held in irrevocable trust for Marc Bienaime
Common Stock 20,000 Indirect Held in irrevocable trust for Aurelie Mitsuki Bienaime and Anais Kimiko
Footnotes
  1. Transaction made pursuant to a Rule 10b5-1 plan executed on November 12, 2012.
  2. The reporting person and his spouse act as trustees for the Bienaime Family Trust.
  3. The reporting person's spouse is trustee of each child's trust.
  4. This stock option is fully vested, an therefore is currently exercisable for 100% of shares.
  5. Reflects number of stock options outstanding after the transaction from this specific stock option grant.